Loading viewer...
investor_presentation
Format: PDF investor_presentation
Science Applications International Corporation Fiscal Year 2023 Second Quarter Earnings Call Supplemental Financial Presentation September 1, 2022
Science Applications International Corporation
Fiscal Year 2023 Second
Quarter Earnings Call
Supplemental Financial Presentation
September 1, 20223 SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED ICertain statements in this presentation are “forward-looking statements” within the meaning of the Private Securities Litigation Reform
Act of 1995. Words such as “may,” “will,” “should,” “expects,” “intends,” “projects,” “plans,” “believes,” “estimates,” “targets,” “anticipates,”
and similar expressions identify forward-looking statements in this presentation. Such statements include, but are not limited to,
statements about future financial and operating results, plans, objectives, expectations and intentions, and other statements that are not
historical facts. These statements are subject to numerous assumptions, risks, and uncertainties, and other factors, many of which are
outside the control of SAIC. These factors could cause actual results to differ materially from such forward-looking statements. Risks,
uncertainties and assumptions that could cause SAIC’s actual results to differ materially from those discussed in the forward-looking
statements include, but are not limited to, those described in the “Risk Factors” section of SAIC’s most recent Form 10-K filed with the
Securities and Exchange Commission (“SEC”) and updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the
SEC. The reports referenced above are available on SAIC’s website at www.saic.com or on the SEC’s website at www.sec.gov. No
assurance can be given that the results of events described in forward-looking statements will be achieved and actual results may differ
materially from these statements. SAIC disclaims any obligation to update any forward-looking statements provided in this presentation
to reflect subsequent events, actual results, or changes in SAIC’s expectations.
In addition, these slides should be read in conjunction with our earnings press release dated September 1, 2022 along with listening to or
reading a transcript of the management comments delivered in an earnings conference call held on September 1, 2022.
All information in these slides are as of September 1, 2022. SAIC expressly disclaims any duty to update any forward-looking statement
provided in this release to reflect subsequent events, actual results or changes in SAIC’s expectations. SAIC also disclaims any duty to
comment upon or correct information that may be contained in reports published by investment analysts or others.Forward Looking Statement4 SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED IT oday’s Presenters
Chief Financial OfficerNazzic Keene
Chief Executive Officer
5 SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED I
6 SAIC PROPRIETARY INFORMATION I © SAIC. ALL RIGHTS RESERVED ISAIC’s Enterprise Focus Areas
Strategy designed to capture accelerated share across a focused set of market needs
Preview truncated — download the full document for the complete content.
presentation
investor_presentation
57 Pages
Protagonist Therapeutics